References

• 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
• 2010Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing287 cited
• 2007Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services154 cited
• 2003Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.126 cited
• 2006Assessing the impact of HBV NAT on window period reduction and residual risk114 cited
• 2005Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus107 cited
• 2007Reducing the risk of transfusion‐transmissible viral infection through blood donor selection: the Australian experience 2000 through 200687 cited
• 2011Views and experiences of men who have sex with men on the ban on blood donation: a cross sectional survey with qualitative interviews75 cited
• 2007The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in Australia60 cited
• 2011Donor understanding and attitudes about current and potential deferral criteria for high‐risk sexual behavior55 cited
• 2006Surveillance of risk profiles among new and repeat blood donors with transfusion‐transmissible infections from 1995 through 2003 in the Netherlands52 cited
• 2010